PINNACLE ASSOCIATES LTD - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$16,126,396
-29.4%
1,016,156
-16.0%
0.30%
-24.2%
Q2 2023$22,831,247
+348.2%
1,209,923
-8.8%
0.40%
+280.8%
Q1 2023$5,093,679
-23.0%
1,326,479
-0.5%
0.10%
-27.8%
Q4 2022$6,614,448
+2.6%
1,333,558
-1.1%
0.14%
-2.7%
Q3 2022$6,448,000
+3.1%
1,348,963
-3.0%
0.15%
+8.8%
Q2 2022$6,257,000
-6.4%
1,390,532
-1.0%
0.14%
+15.3%
Q1 2022$6,686,000
-24.0%
1,404,668
+18.4%
0.12%
-22.4%
Q4 2021$8,801,000
+80.1%
1,186,058
+37.6%
0.15%
+68.9%
Q3 2021$4,887,000
-16.8%
861,882
-3.3%
0.09%
-15.1%
Q2 2021$5,876,000
-17.4%
891,727
+1.6%
0.11%
-22.1%
Q1 2021$7,112,000
+13.1%
878,058
-10.0%
0.14%
+6.2%
Q4 2020$6,291,000
+67.9%
975,418
-6.2%
0.13%
+43.8%
Q3 2020$3,746,000
-25.1%
1,040,431
-4.3%
0.09%
-27.6%
Q2 2020$5,000,000
+33.5%
1,087,034
-1.0%
0.12%
+7.9%
Q1 2020$3,744,000
-42.3%
1,098,005
-13.6%
0.11%
-19.7%
Q4 2019$6,489,000
+97.4%
1,271,187
-6.4%
0.14%
+84.4%
Q3 2019$3,287,000
+5.2%
1,358,127
-5.7%
0.08%
+5.5%
Q2 2019$3,125,000
-28.3%
1,439,865
-10.4%
0.07%
-25.5%
Q1 2019$4,357,000
-0.1%
1,607,596
+76.9%
0.10%
-13.3%
Q4 2018$4,362,000
-51.1%
908,776
-3.5%
0.11%
-38.9%
Q3 2018$8,922,000
-16.4%
942,180
-14.1%
0.18%
-15.9%
Q2 2018$10,673,000
-20.0%
1,096,937
-13.5%
0.22%
-15.7%
Q1 2018$13,334,000
+57.3%
1,267,507
-4.1%
0.26%
+60.1%
Q4 2017$8,476,000
-24.5%
1,322,231
-9.8%
0.16%
-21.3%
Q3 2017$11,220,000
+4.0%
1,466,679
-3.4%
0.21%0.0%
Q2 2017$10,790,000
+75.4%
1,517,639
-4.5%
0.21%
+75.4%
Q1 2017$6,153,000
+85.8%
1,589,959
-2.0%
0.12%
+76.1%
Q4 2016$3,311,000
-29.0%
1,623,124
-6.7%
0.07%
-28.0%
Q3 2016$4,661,000
-14.3%
1,739,176
-1.5%
0.09%
-20.5%
Q2 2016$5,439,000
-65.1%
1,766,046
-3.5%
0.12%
-65.0%
Q1 2016$15,600,000
-35.0%
1,830,939
+3.5%
0.33%
-33.6%
Q4 2015$23,997,000
+104.5%
1,768,359
+44.6%
0.50%
+93.5%
Q3 2015$11,737,000
-35.3%
1,222,575
-3.1%
0.26%
-22.8%
Q2 2015$18,138,000
+59.4%
1,261,320
-0.8%
0.34%
+59.0%
Q1 2015$11,381,000
+50.6%
1,271,640
+2.6%
0.21%
+43.2%
Q4 2014$7,558,000
-42.3%
1,239,092
+0.3%
0.15%
-44.4%
Q3 2014$13,088,000
+31.9%
1,235,862
+47.6%
0.27%
+37.1%
Q2 2014$9,923,000
-24.8%
837,357
-5.2%
0.19%
-24.5%
Q1 2014$13,193,000
-2.4%
883,647
-4.1%
0.26%
-2.7%
Q4 2013$13,513,000
-15.6%
921,157
-2.1%
0.26%
-20.2%
Q3 2013$16,013,000
+1.7%
940,853
-0.9%
0.33%
-6.5%
Q2 2013$15,753,000949,5750.35%
Other shareholders
IMMUNOGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders